Loading provider…
Loading provider…
Hematology & Oncology Physician in Boston, MA
NPI: 1043303688Primary Practice Location
MASSACHUSETTS GENERAL HOSPITAL
55 Fruit St, Boston, MA
Primary Employer
Massachusetts General Hospital
massgeneral.org
HQ Phone
Get M.D. Revati's Phone Numberphone_androidMobile
Get M.D. Revati's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMA State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 134 | 312 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 79 | 334 |
| 3 | 99205New patient office or other outpatient visit, typically 60 minutes | 23 | 23 |
| 4 | 99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 22 | 27 |
| 5 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 16 | 46 |
Lead Sponsor: Massachusetts General Hospital
Collaborators: National Comprehensive Cancer Network
Intervention / Treatment: OTHER: Usual Care, BEHAVIORAL: Supportive Care Mobile Application
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: BIOLOGICAL: Nivolumab, PROCEDURE: Positron Emission Tomography, PROCEDURE: Biospecimen Collection, PROCEDURE: Computed Tomography, PROCEDURE: Echocardiography Test, OTHER: Observation Activity
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Laboratory Biomarker Analysis, OTHER: Clinical Observation, OTHER: Placebo Administration, DRUG: Erlotinib Hydrochloride